logo
Las Vegas sees fall in tourists as 'ridiculous prices' hit

Las Vegas sees fall in tourists as 'ridiculous prices' hit

Daily Mail​10 hours ago
Las Vegas 's high prices could be putting off potential tourists, according to new visitor figures.
Tourist numbers have fallen every month this year with 6.5 per cent fewer visitors than in 2024, according to the Las Vegas Convention and Visitors Authority.
International arrivals at Harry Reid Airport were 8.7 per cent lower in May than the same month in 2024.
It is thought that Sin City's soaring prices could be to blame for its falling visitor numbers.
A visitor recently shared her shock after she was charged $26/£19.11 for a bottle of Fiji water from the minibar in her room at the Aria Resort & Casino.
And a British magician was also left outraged after he was billed $74.31/£54.63 for two drinks at Sphere in Las Vegas.
Anthony Curtis, publisher of the Las Vegas Advisor website, told The Times: 'On the Strip, people get taken for a ride.
'Once they get here they're like, "I've had enough of this crap, I'm tired of being treated like this. I'm tired of having to pay these ridiculous prices".'
The Vegas expert explained that many casinos have 'turned their back on the middle market' in order to focus on more affluent tourists.
A 2024 study found that the average income of Las Vegas holidaymakers is now $93,000/£68,365, with many budget travellers priced out of the gambling capital.
In a Reddit post, a person who recently visited Vegas describes the city as 'amazing' but 'absurdly priced'.
The user writes: 'Walking around the different themed casinos was like a fever dream. Sadly I felt like a spectator instead of a participant. I have honestly never been to a place that was more absurdly priced.'
They claim they had to spend $30/£22 on a glass of house wine and were charged $50/£36 for two bottles of water from the minibar.
On another Reddit thread, a user says Las Vegas is 'extortionately expensive'. They wrote: 'I live in a very high cost of living area.
'Vegas is extortionately expensive. Shows. Restaurants. Everything is far more expensive in Vegas than here.'
Meanwhile, another commenter says: 'I used to love going Vegas, but the last few times I had sticker shock on everything.
'It doesn't feel like a relaxing, exciting vacation when you're price gouged up to your ears and come home feeling robbed.'
However, another traveller claims it is still possible to enjoy Vegas on a budget.
They said: 'People come to Vegas expecting champagne on a beer budget.
'You can have an amazing time in Vegas on any budget, but if your budget is on the lower end, then you may have to forego some experiences and types of restaurants.'
And another user writes: 'Yes Vegas is expensive, but it's a high end destination in a tourist area and you're getting some of the best food and service in the world.'
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Southwest Airlines accuses drugmakers of price-fixing conspiracy in new lawsuit
Southwest Airlines accuses drugmakers of price-fixing conspiracy in new lawsuit

Reuters

time23 minutes ago

  • Reuters

Southwest Airlines accuses drugmakers of price-fixing conspiracy in new lawsuit

July 7 (Reuters) - Southwest Airlines (LUV.N), opens new tab has sued a group of drugmakers in U.S. court for allegedly participating in a price-fixing conspiracy that caused the airline to overpay for purchases of hundreds of millions of dollars in medications for employees. Southwest alleged it was overcharged by generic drugmakers including Sandoz, Teva and Sun starting in May 2009. The lawsuit, opens new tab, filed in the federal court in Philadelphia and unsealed on July 3, said the companies violated antitrust law by coordinating on pricing. Sandoz, Teva and Sun did not immediately respond to requests for comment. Southwest in a statement said it sued after discovering evidence of what it called a widespread price-fixing conspiracy among dozens of generic drug makers. State attorneys general and other plaintiffs are pursuing related antitrust allegations against generic drugmakers in federal court in Connecticut. Related class actions from drug wholesalers and others are pending in the Philadelphia court. Generic drugmakers Apotex and Heritage Pharmaceuticals last year agreed to pay nearly $50 million to settle claims by Connecticut and other states that accused them of conspiring to artificially inflate prices. Switzerland-based Sandoz in February agreed to pay $275 million to resolve claims by U.S. consumers and others who had accused the company of conspiring to fix prices. Southwest paid health claims for its employees and retirees from its corporate assets and did not otherwise rely on third-party insurance. The airline's lawsuit said it paid 'massive' unspecified overcharges for generic medications. The complaint said generic drugmakers were 'systematically and routinely communicating with each other directly about bids, pricing, and market entries and exits for hundreds of generic drugs.' Other employers — including General Motors, Target and American Airlines — had sued the same defendants last year, claiming billions of dollars in overcharges. The case is Southwest Airlines Co v. Actavis Holdco U.S. Inc et al, U.S. District Court for the Eastern District of Pennsylvania, No. 2:25-cv-02951-CMR. For plaintiffs: Karma Giulianelli and Sundeep Addy of Bartlit Beck For defendants: No appearances yet Read more: AstraZeneca agrees to $51 million settlement in Seroquel antitrust class action 20 US states balk at Florida settlement with drugmaker Sandoz Sandoz to pay $275 million to settle drug price-fixing case Drugmakers Apotex, Heritage to pay $49 mln to resolve states' price-fixing claims

Taoiseach ‘hopeful' of EU-US deal as tariff deadline pushed back
Taoiseach ‘hopeful' of EU-US deal as tariff deadline pushed back

BreakingNews.ie

timean hour ago

  • BreakingNews.ie

Taoiseach ‘hopeful' of EU-US deal as tariff deadline pushed back

The Taoiseach remains 'hopeful' that the EU can reach a deal with the US on tariffs, as the Trump administration pushed back a deadline for increased rates. Micheál Martin said both sides continue to negotiate the 'fine detail' of future arrangements. Advertisement White House Press Secretary Karoline Leavitt announced on Monday that US President Donald Trump would be delaying an increase to the baseline 10 per cent tariff rate to August 1st. President of the European Commission Ursula von der Leyen. Photo: Carl Court/PA. Countries had been working to a Wednesday deadline to make a new deal with the Trump administration. Speaking to the media after a phone call with European Commission President Ursula von der Leyen on Monday, Mr Martin said: 'We remain hopeful that the US and the European Union can agree an outline agreement or framework principle agreement this week. 'There's still a number of issues to negotiated, nothing has been rejected, definitively. Advertisement 'But what it does illustrate, though, that even if a framework agreement is arrived at, there would be a lot of negotiations subsequently. 'So therefore, whilst it would create some degree of clarity in terms of where we are in the short term, there would still be a number of issues outstanding in respect of that trade issue between the European Union and the United States and indeed between other countries.' Mr Martin said he supported the Commission's position that an agreement should be reached to provide certainty to consumers, businesses and industry. US Ambassador to Ireland Edward S Walsh with Tanaiste Simon Harris. Photo: Brian Lawless/PA. Asked if he expected a 10 per cent baseline tariff to remain in place, the Taoiseach said: 'There are certain realities that probably will emerge from this that will have impact – and are having impact – on a number of sectors. Advertisement 'But at least it gives us some sense of the landscape that we have to deal with.' After the tariff deadline was pushed back, Tánaiste Simon Harris said this would give further time for the EU and US to reach an agreement in principle on a 'mutually beneficial agreement that works for both sides'. In a statement, he said: 'However, it remains the position of the EU and the Irish Government that we would like to conclude discussions on a trade agreement before August 1.' Mr Harris added: 'I remain cautiously optimistic about reaching agreement in principle on a Framework Agreement. Advertisement 'I want to be clear that while it is likely there will be some form of tariffs going forward, their imposition even at a lower rate is bad for consumers, jobs, economic growth and investment.' World Trump seeks to pressure trading partners to make d... Read More Ireland has consistently called for zero-for-zero tariffs in as many areas as possible. The remaining uncertainty around pharmaceuticals remains a significant cause of concern. Mr Harris said: 'My hope is that in the coming days and weeks both sides can work intensively and constructively to bring about an agreement.' Advertisement

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store